Christian Mayr
Salzburg, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Emerging claudin-18.2 antagonists in the treatment of biliary tract cancer.
Journal: Expert opinion on emerging drugs
Published: June 03, 2026
New frontiers in the pharmacological management of biliary tract carcinomas: the emerging role of drug conjugates.
Journal: Expert opinion on pharmacotherapy
Published: April 17, 2025
The importance of preclinical models for cholangiocarcinoma drug discovery.
Journal: Expert opinion on drug discovery
Published: January 22, 2025
The Cdk inhibitor dinaciclib as a promising anti-tumorigenic agent in biliary tract cancer.
Journal: Cancer biology & therapy
Published: December 13, 2024
Cannabidiol Is a Potential Inhibitor of Ferroptosis in Human Articular Chondrocytes.
Journal: Journal of cellular and molecular medicine
Published: October 24, 2024
The efficacy of ferroptosis-inducing compounds IKE and RSL3 correlates with the expression of ferroptotic pathway regulators CD71 and SLC7A11 in biliary tract cancer cells.
Journal: PloS one
Published: February 05, 2024
Editorial: Novel therapeutic approaches for biliary tract cancer and hepatocellular carcinoma.
Journal: Frontiers in cell and developmental biology
Published: October 11, 2023
New insights into possible HDAC inhibitor resistance in DLBCL - Comment on 'defining cellular responses to HDAC-selective inhibitors reveals that efficient targeting of HDAC3 is required to elicit cytotoxicity and overcome naïve resistance to pan-HDACi in diffuse large B cell lymphoma' by Havas et al.
Journal: Translational oncology
Published: October 03, 2023
HDACs as an emerging target in endocrine tumors: a comprehensive review.
Journal: Expert review of endocrinology & metabolism
Published: March 06, 2023
Evaluation of Tazemetostat as a Therapeutically Relevant Substance in Biliary Tract Cancer.
Journal: Cancers
Published: January 05, 2023
Ouabain at nanomolar concentrations is cytotoxic for biliary tract cancer cells.
Journal: PloS one
Published: December 06, 2022
MicroRNA mimics can distort physiological microRNA effects on immune checkpoints by triggering an antiviral interferon response.
Journal: RNA biology
Published: December 05, 2022
Last Updated: 09/26/2026